CPA250117C115000
- 0.30
- 0.000.00%
Copa Holdings Newsroom
Morgan Stanley Maintains Copa Holdings(CPA.US) With Buy Rating, Cuts Target Price to $120
Copa Holdings' Steady Growth and Operational Efficiency Justifies Buy Rating by Jens Spiess
J.P. Morgan Maintains Copa Holdings(CPA.US) With Buy Rating, Cuts Target Price to $170
TD Cowen Maintains Copa Holdings(CPA.US) With Buy Rating, Maintains Target Price $130
Barclays Maintains Copa Holdings(CPA.US) With Buy Rating, Maintains Target Price $150
Barclays Sticks to Its Buy Rating for Copa Holdings (CPA)
TD Cowen Maintains Copa Holdings(CPA.US) With Buy Rating, Maintains Target Price $130
Copa Holdings: Strategic Cost Management and Fleet Adjustments Support Buy Rating
Evercore Maintains Copa Holdings(CPA.US) With Buy Rating, Maintains Target Price $150
Evercore ISI Sticks to Their Buy Rating for Copa Holdings (CPA)
BofA Securities Maintains Copa Holdings(CPA.US) With Buy Rating, Raises Target Price to $165
Copa Holdings: Strong Financial Performance and Attractive Valuation Justify Buy Rating
Barclays Maintains Copa Holdings(CPA.US) With Buy Rating, Maintains Target Price $150
Analysts Offer Insights on NA Companies: Copa Holdings (CPA) and Gauzy Ltd. (GAUZ)
Morgan Stanley Maintains Copa Holdings(CPA.US) With Buy Rating, Maintains Target Price $130
Analysts Offer Insights on NA Companies: Kyverna Therapeutics, Inc. (KYTX), Mural Oncology Plc (MURA) and Copa Holdings (CPA)
TD Cowen Maintains Copa Holdings(CPA.US) With Buy Rating, Maintains Target Price $130
Copa Holdings: Buy Rating Affirmed Amid Optimistic Projections and Resilient Growth
Morgan Stanley Maintains Copa Holdings(CPA.US) With Buy Rating, Maintains Target Price $130
Copa Holdings: Strong Growth and Operational Efficiency Justify Buy Rating